Risk of a recurrent cardiovascular event in individuals with type 2 diabetes or intermediate hyperglycemia: the Hoorn

Amber A W A van der Heijden1, Esther Van't Riet, Sandra D M Bot

  • 1Corresponding author: Amber A.W.A. van der Heijden, a.vanderheijden@vumc.nl.

Diabetes Care
|July 24, 2013
PubMed

Insights

Individuals with type 2 diabetes face a higher risk of recurrent cardiovascular events. Early identification of at-risk patients using pre-event profiles is crucial for managing cardiovascular disease.

Area of Science:

  • Cardiology
  • Endocrinology
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) poses a significant health burden.
  • Understanding risk factors for recurrent CVD events is critical for patient management.
  • Glucose metabolism plays a role in cardiovascular health.

Purpose of the Study:

  • To determine the risk of recurrent cardiovascular events in a population-based cohort.
  • To identify predictors of recurrent cardiovascular events.
  • To compare event risk across different glucose metabolism statuses.

Main Methods:

  • Prospective follow-up of 336 individuals with a first cardiovascular event (Hoorn Study).
  • Calculation of absolute risk for recurrent events based on glucose metabolism (normal, intermediate hyperglycemia, type 2 diabetes).
  • Cox regression models used to identify predictors of recurrent events.

Main Results:

  • 44% of participants experienced a recurrent vascular event during a median 4.1-year follow-up.
  • Recurrent event rates per 100 person-years were 7.2 (normal glucose), 9.8 (intermediate hyperglycemia), and 12.5 (type 2 diabetes).
  • Predictors included higher age, male sex, waist circumference, systolic blood pressure, HbA1c, and family history of myocardial infarction.

Conclusions:

  • Type 2 diabetes is associated with an increased risk of recurrent vascular events compared to normal glucose metabolism.
  • Intermediate hyperglycemia did not show a statistically significant increased risk.
  • Patient risk profiles established before the first event can identify individuals at higher risk for recurrence.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...